跳至主要内容
临床试验/CTRI/2024/08/072244
CTRI/2024/08/072244尚未招募2 期

A randomised controlled clinical trail to study the effect of vidangadi nasya in ardhavahedaka with special reference to simple migraine.

Dr Swarada Gadekar1 个研究点 分布在 1 个国家目标入组 62 人开始时间: 2024年8月17日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
62
试验地点
1
主要终点
Reduction in signs and symptoms of Ardhavabhedaka after administration of Vidangadi nasya

研究概览

简要总结

Ardha means half side of the head and Bhedaka means perforating type of pain it is the disease having symptoms of Uttamanga ardhabhaga sambhedana toda ,bhrama. Ardhavabhedaka can co-relate with migraine mentioned in allopathic medicine. It is typically unilateral headache affecting one half of head varied with intensity normally accompanied by nausea and vomiting. The prevalence of Migraine 12%.Vidang is the drug which is Vaatkaphaghna and Shirovirechanopag ; therefore for the present study Vidang is selected and with Vidang Tila with Snigdha gunas and Vaatahara properties is used. Patients having the cardinal features of Ardhavabhedaka (Migraine without aura) aged between 18-60 years ,patients fit for Nasya Karma will be included irrespective of sex, religion and caste, written consent from patient will be taken prior to study. Computerised generated Sampling technique will be used. Total 62 number of patients will be selected and divided into two groups, named as Group A (trial group) and Group B (Control group). Vidangadi Nasya  group A (Trial group) with 4 drops OD for 7 days and Goghritamanda Nasya Group B (Control group) with 4 drops OD for 7 days will be given to the patient. Observations will be done on day 0, day 3, day 5 & day 7. Result of study will be drawn on the basis of criteria of assessment and statistical analysis. Discussion will be done on the basis of observations and result obtained during the treatment. Summary will be drawn and whole thesis work will be summarized. Conclusion will be drawn strictly on basis of statistical analysis and will be unbiased.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
Participant Blinded

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • a) Patients having the cardinal features of Ardhavabhedaka (Migraine without aura) b) Patients aged between 18-60 years.
  • c) Patients will be included irrespective of sex, religion and caste.
  • d) Patients fit for Nasya Karma.

排除标准

  • a) Patients having a history of head trauma and other types of headaches.
  • b) Patients having any inflammatory diseases in nose ,PNS ,eyes and ears.
  • c) Patients with other systemic disorder’s like hypertention ,diabetes mellitus etc.

结局指标

主要结局

Reduction in signs and symptoms of Ardhavabhedaka after administration of Vidangadi nasya

时间窗: 7 days

次要结局

  • Where the trial group stands in comparison with control group(18 months)

研究者

发起方
Dr Swarada Gadekar
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Swarada Ashok Gadekar

SMBT Ayurved College and Hospital

研究点 (1)

Loading locations...

相似试验